pre-IPO PHARMA

quanta-therapeutics PRESS RELEASE ARCHIVE

May 22, 2023

Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors


Apr 14, 2023

Quanta Therapeutics Presents Data from KRAS Inhibitor Pipeline at Annual AACR Meeting in Late-Breaking Research Session


Mar 14, 2023

Quanta Therapeutics Announces Two Late-Breaking Preclinical Presentations from KRAS Inhibitor Pipeline at Annual AACR Meeting


Dec 13, 2022

Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief Medical Officer


Oct 26, 2021

Quanta Therapeutics Announces Oversubscribed $60 Million Series C Financing to Advance Novel RAS-targeting Programs



Google Analytics Alternative